CME: Prevention and management of influenza infection
Cost: FreeView Offer chevron_right
Influenza has been recognized as a global public health menace since at least 100 years ago with the 1918-19 pandemic, which infected an estimated one-third of the world’s population and was responsible for the deaths of one in ten, or 50 million, of those infected. While some have contended that a significant number of deaths associated with the 1918 pandemic may have actually been attributable to acid-base derangements and pulmonary edema associated with contemporary aspirin dosing in the toxic range of two to eight times what is presently the maximum recommended dose – it remains a significant public health concern, with the 2017-2018 flu season in recent decades with an estimated 80,000 deaths (typical range 12,000-56,000 per year),coming with an annual cost of $16 billion.
By the end of the session the participant will be able to:
- Determine the impact of influenza infection
- Describe influenza vaccination recommendations and apply them to patient cases
- Describe treatment recommendations and apply them to patient cases
- Describe present challenges to the prevention and treatment of influenza and develop strategies to combat them
Healthcare professionals specializing in: infectious disease, internal medicine, and pediatrics; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned areas; and any other healthcare professionals with an interest in or who clinically encounter patients with influenza.